Skip to content
Study details
Enrolling now

Focused Extracorporeal Shockwave Therapy for Knee Arthritis

Kessler Foundation
NCT IDNCT05596591ClinicalTrials.gov data as of Apr 2026
Target enrollment

15

Study length

about 4.2 years

Ages

30–80

Locations

2 sites in NJ

About this study

Researchers are testing whether focused extracorporeal shockwave therapy can help with knee pain and function in people with knee arthritis. This treatment uses sound waves to try to improve the condition of bone marrow lesions (BMLs) in the knee, which are linked to pain and other problems. The trial will compare this treatment to standard care, such as pain relievers and protected weight-bearing.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Use Focused extracorporeal shockwave therapy
Primary goalChange in knee pain numerical rating scale scores

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low9%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Endpoints

Primary: Change in knee pain numerical rating scale scores

Secondary: Change in knee pain numerical rating scale scores, Change in whole-organ MRI scoring (WORMS)-Subchondral bone scale

Body systems

Musculoskeletal